Tharimmune's TH104 Program Gains FDA Support to Combat Opioid Overdose Risks Tharimmune has received encouraging feedback from the FDA for its TH104 program, a significant step towards counteracting respiratory depression caused by opioids.

Tharimmune's TH104 Program Gains FDA Support to Combat Opioid Overdose Risks #United_States #FDA #Red_Bank #Tharimmune #TH104